CTC1 Gene Mutation Analysis
The CTC1 gene is located on the short (p) arm of chromosome 17 at position 13.1 and encodes the CTC1 protein that is important in telomere maintenance. Telomeres are short, repetitive segments of DNA at the ends of chromosomes that keep them from abnormally sticking together or degrading. The CTC1 protein is part of the CST complex, which protects telomeres from shortening that may occur during cell division. The CTC1 protein may also form a heterodimer with STN1 to form the enzyme ‘alpha accessory factor’ that regulates DNA replication. Mutations in the CTC1 gene are associated with Coats plus syndrome (Cerebroretinal microangiopathy with calcifications and cysts 1) and some cases of Dyskeratosis congenita (DC).
Coats plus syndrome is a rare autosomal recessive neurological disorder due to mutations in the CTC1 gene. It is characterized by retinal telangiectasias and exudates (Coats disease) as well as intercranial calcifications, leukodystrophy and brain cysts. Neurologically the disorder is characterized by spasticity, ataxia, dystonia, seizures and cognitive decline. Extra-neurologic features include; osteoporosis with poor bone healing, portal hypertension and gastrointestinal hemorrhage secondary to vascular ectasias in the stomach, liver and small intestine. Interestingly, Coats plus patients may also have hair , skin and nail features similar to Dyskeratosis congenita. Most people with Coats plus syndrome are compound heterozygotes for CTC1 gene mutations in which one gene is silenced and the other has reduced activity. This combination of mutations leaves only a small amount of functional CTC1 protein available to work as part of the CST complex resulting in telomere shortening and premature cell death.
Mutations in CTC1 are found in 1-3% of Dyskeratosis congenita (DC) patients. Dyskeratosis congenital is characterized by the triad of; lacy skin pigmentation of the upper chest and neck, dystrophic nails, and oral leukoplakia. Other features include; epiphora, developmental delay, respiratory disease, short stature, poor dentition, esophageal strictures, premature hair loss and an increased risk for bone marrow failure and a variety of malignancies. Individuals typically present during early childhood. Missense and frameshift mutations result in dysfunction of the CTC1 protein and CST complex, interfering with its protection of telomeres and leading to reduced telomere length.
- Diagnostic conformation of dyskeratosis congenital and Coats plus syndrome
- For the carrier testing in family members of the affected patient
- To confirm that a potential hematopoietic stem cell transplant donor is not affected
Positive: Mutation or pathogenic variant in CTC1 gene. Pathogenic variants may include small intragenic deletions/insertions and missense, nonsense, and splice site variants.
Negative: No mutation or pathogenic variant in CTC1 gene.
Negative for mutation or pathogenic variant in CTC1 gene
Whole blood, Cultured cells, Skin biopsy.
Stability (whole blood)
- Ambient: 3-5 days
- Refrigerated: 7-14 days
- Frozen: unacceptable
- EMBO J. 2012;31: 2309-21. [PMID: 22531781]
- Genes Dev. 2013;27: 2099-108. [PMID: 24115768]
- J Neurol. 2014;261: 1911-6. [PMID: 25034270]
- Genes Dev. 2013;27: 2099-108. [PMID: 24115768]
- Aging Cell. 2013;12(6):1100-9. [PMID: 23869908]
- Am J Hum Genet. 2012;90(3):540-9. [PMID: 22387016]
- Nat Genet. 2012;44: 338-42. [PMID: 22267198]
- Genetics Home Reference. Available: https://ghr.nlm.nih.gov/gene/CTC1#